A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. A, 1997, Pages 59-62

  Bebear C ^a   Bouanchaud, D H ^b  

^a HÔPITAL PELLEGRIN   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; QUINUPRISTIN; STREPTOGRAMIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; LEGIONELLA; LEGIONELLA PNEUMOPHILA; MYCOPLASMA; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; REVIEW; STAPHYLOCOCCUS AUREUS; UREAPLASMA UREALYTICUM;

ANIMALS; ANTI-BACTERIAL AGENTS; LEGIONELLA; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA; STAPHYLOCOCCUS AUREUS; VIRGINIAMYCIN;

EID: 1842405369     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_1.59     Document Type: Review

References (21)

1. van den Broek, P. J. (1989). Antimicrobial drugs. Microorganisms and phagocytes. Reviews of Infectious Diseases 11, 213-45.
2. Holmes, B., Quie, P. G., Windhorst, D. B., Pollara, B. & Good, R. A. (1966). Protection of phagocytosed bacteria from the killing action of antibiotics. Nature 210, 1131-2.
3. Johnson, J. D., Hand, L. W., Francis. J. B., King-Thompson, N. & Corwin, R. W. (1980). Antibiotic uptake by alveolar macrophages. Journal of Laboratory and Clinical Medicine 95, 429-39.
4. Tulkens, P. & Trouet, A. (1978). The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured fibroblasts. Biochemical Pharmacology 27, 415-24.
5. Hand, W. L. & King-Thompson, N. L. (1982). Membrane transport of clindamycin in alveolar macrophages. Antimicrobial Agents and Chemotherapy 21, 241-7.
6. Höger, P. H., Vosbeck, K., Seger, R. & Hitzig, W. H. (1985). Uptake, intracellular activity and influence of rifampicin on normal function of polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 28, 667-74.
7. Carlone, N. A., Cuffini, A. M., Ferraro, M., Tullio, V. & Avetta, G. (1989). Cellular uptake and intracellular bactericidal activity of teicoplanin in human macrophages. Journal of Antimicrobial Chemotherapy 23, 849-59.
8. Desnottes, J. F. & Diallo, N. (1990). Etude comparée de la pénétration intra-macrophagique et de l'action sur la phagocytose d'un macrolide (spiramycine) et d'une fluoroquinolone (péfloxacine). Pathologie Biologie 38, 281-5.
9. Sanchez, M. S., Ford, C. W. & Yancey, R. J. (1986). Evaluation of antibacterial agents in a high-volume bovine polymorphonuclear neutrophil Staphylococcus aureus intracellular killing assay. Antimicrobial Agents and Chemotherapy 29, 634-8.
10. Steinberg, T. H. & Hand, W. L. (1987). Effect of phagocytic membrane stimulation on antibiotic uptake and intracellular bacteriocidal activity. Antimicrobial Agents and Chemotherapy 31, 660-2.
11. van der Auwera, P., Matsumoto, T. & Husson, M. (1988). Intraphagocytic penetration of antibiotics. Journal of Antimicrobial Chemotherapy 22, 185-92.
12. Rogers, D. E. & Tompsett, R. (1952). The survival of staphylococci within human leukocytes. Journal of Experimental Medicine 95, 209-30.
13. Mandell, G. L. (1975). Catalase, Superoxide dismutase and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. Journal of Clinical Investigation 55, 561-6.
14. Barrière, J. C., Bouanchaud, D. H., Paris, J. M., Rolin, P., Harris, N. V. & Smith, C. (1992). Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 1-8.
15. Bouanchaud, D. H. (1992). In-vitro and in-vivo synergistic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 95-100.
16. Neu, H. C., Chin, N. & Gu, J. (1992). The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 83-94.
17. Soussy, C. J., Acar, J. F., Cluzel, R., Courvalin, P., Duval, J., Fleurette, J. et al. (1992). A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 53-8.
18. Dubois, J. & Joly, J. R. (1992). In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp. Journal of Antimicrobial Chemotherapy 30, Suppl/ A, 77-81.
19. Johnson, D. M., Erwin, M. E., Barrett, M. S., Briggs Gooding, B. & Jones, R. N. (1992). Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species. European Journal of Clinical Microbiology and infectious Diseases 11, 751-5.
20. Renaudin, H., Boussens, B. & Bebear, C. (1991). In-vitro activity of RP 59500 against Mycoplasmas. In Program and Abstracts of the Thirty-First Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1991. Abstract 897. American Society for Microbiology, Washington, DC.
21. Desnottes, J. F. & Diallo, N. (1992). Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages. Journal of Antimicrobial Chemotherapy 30, Suppl. A. 107-15.